Ma
Maplewood Bio
Cambridge MAFounded 202120 employees
Private CapbiotechPrivateOncology
Platform: Targeted TPD
Market Cap
N/A
All Drugs
4
Clinical Trials
8
Failed / Terminated
1
FDA Approved
1
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Fixatapinarof | MAP-8538 | Phase 2 | 2 | USP1 | DLBCLSchizophrenia | ||
| MAP-6526 | MAP-6526 | Approved | 3 | PD-1 | ACCNMOSD | ||
| Elratapinarof | MAP-3327 | Preclinical | 2 | Nectin-4 | Gastric Ca | ||
| Semacagene | MAP-1226 | Phase 1/2 | 1 | SGLT2 | NBOCD |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (8)